ImmuneInnovstone Therapeutics discloses new cathepsin C inhibitorsInnovstone Therapeutics Ltd. has synthesized cathepsin C (dipeptidyl peptidase I; DPP-1) inhibitors found to be potentially useful for the treatment of autoimmune diseases and cancer.